Amikacin liposome (as amikacin sulfate liposome) 590 mg dispersion for nebuliser vial
RxNorm 2674386

Concept Hierarchy & Relationship Mapping

RxNorm Concept Unique Identifier (RxCUI) 2674386 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Amikacin liposome (as amikacin sulfate liposome) 590 mg dispersion for nebuliser vial.

The following semantic concepts and normalized strings are associated with this clinical entity:

PTGB
Amikacin liposome (as amikacin sulfate liposome) 590 mg dispersion for nebuliser vial
AUI:12871383
View
PT
Amikacin liposome (as amikacin sulfate liposome) 590 mg dispersion for nebulizer vial
AUI:12871384
View
FN
Product containing precisely amikacin liposome (as amikacin sulfate liposome) 590 mg/1 vial conventional release dispersion for nebulizer (clinical drug)
AUI:12872055
View

This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.

PTGB

British preferred term (PTGB):
Amikacin liposome (as amikacin sulfate liposome) 590 mg dispersion for nebuliser vial
(Atom ID: 12871383)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
Amikacin liposome (as amikacin sulfate liposome) 590 mg dispersion for nebuliser vial
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2674386
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12871383
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
PTGB
British preferred term ()
Source Code
1293031002
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
US Edition of SNOMED CT (SNOMEDCT_US)
The official name and abbreviation for the vocabulary source.
Source Version
2026_01_31
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
National Library Of Medicine, NLM is a Charter Member of SNOMED International on behalf of the U.S., National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, 1-888-FIND-NLM (1-888-346-3656), , https://support.nlm.nih.gov/support/create-case/,
Source licensing contact information.
PT

Designated preferred name (PT):
Amikacin liposome (as amikacin sulfate liposome) 590 mg dispersion for nebulizer vial
(Atom ID: 12871384)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
Amikacin liposome (as amikacin sulfate liposome) 590 mg dispersion for nebulizer vial
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2674386
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12871384
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
PT
Designated preferred name ()
Source Code
1293031002
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
US Edition of SNOMED CT (SNOMEDCT_US)
The official name and abbreviation for the vocabulary source.
Source Version
2026_01_31
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
National Library Of Medicine, NLM is a Charter Member of SNOMED International on behalf of the U.S., National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, 1-888-FIND-NLM (1-888-346-3656), , https://support.nlm.nih.gov/support/create-case/,
Source licensing contact information.
FN

Full form of descriptor (FN):
Product containing precisely amikacin liposome (as amikacin sulfate liposome) 590 mg/1 vial conventional release dispersion for nebulizer (clinical drug)
(Atom ID: 12872055)

Clinical Status & Identity

Prescribable Status
NO (Reference)
Part of the RxNorm Current Prescribable Content subset including all drugs available for prescription in the USA.
Concept Description
Product containing precisely amikacin liposome (as amikacin sulfate liposome) 590 milligram/1 vial conventional release dispersion for nebulizer (clinical drug)
Official description of the drug concept as defined in the source vocabulary.
Suppress Flag
N
N: Not suppressible | O: Obsolete | Y: Suppressed by editor | E: Unquantified non-prescribable drug.

Interoperability & Coding

Concept ID (RxCUI)
2674386
RxNorm Unique Identifier for the standardized concept.
Atom ID (RXAUI)
12872055
Unique identifier for this specific name variation (Atom).
Term Type (TTY)
FN
Full form of descriptor ()
Source Code
1293031002
The "Most useful" identifier asserted by the original source vocabulary.

Source & Registry Data

Source Name
US Edition of SNOMED CT (SNOMEDCT_US)
The official name and abbreviation for the vocabulary source.
Source Version
2026_01_31
The specific version of the vocabulary provided by the source.
Update Date
June 01, 2026
The date when this RxNorm data was last updated by the NLM.
License Contact
National Library Of Medicine, NLM is a Charter Member of SNOMED International on behalf of the U.S., National Library of Medicine, 8600 Rockville Pike, , Bethesda, MD, United States, 20894, 1-888-FIND-NLM (1-888-346-3656), , https://support.nlm.nih.gov/support/create-case/,
Source licensing contact information.